PA8586601A1 - Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina - Google Patents

Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina

Info

Publication number
PA8586601A1
PA8586601A1 PA20038586601A PA8586601A PA8586601A1 PA 8586601 A1 PA8586601 A1 PA 8586601A1 PA 20038586601 A PA20038586601 A PA 20038586601A PA 8586601 A PA8586601 A PA 8586601A PA 8586601 A1 PA8586601 A1 PA 8586601A1
Authority
PA
Panama
Prior art keywords
organic
acid
isomero
benzhidril
bencilaminoquinuclidina
Prior art date
Application number
PA20038586601A
Other languages
English (en)
Spanish (es)
Inventor
Thomas C Nugent
Robert Seemayer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8586601A1 publication Critical patent/PA8586601A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PA20038586601A 2002-10-16 2003-10-16 Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina PA8586601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41905102P 2002-10-16 2002-10-16

Publications (1)

Publication Number Publication Date
PA8586601A1 true PA8586601A1 (es) 2005-02-04

Family

ID=32108014

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038586601A PA8586601A1 (es) 2002-10-16 2003-10-16 Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina

Country Status (21)

Country Link
US (2) US6861526B2 (enExample)
EP (1) EP1551833A4 (enExample)
JP (1) JP2006506368A (enExample)
KR (1) KR100739901B1 (enExample)
CN (1) CN100418964C (enExample)
AP (1) AP2005003288A0 (enExample)
AR (1) AR041587A1 (enExample)
AU (1) AU2003277353B2 (enExample)
BR (1) BR0315335A (enExample)
CA (1) CA2500635A1 (enExample)
EA (1) EA008192B1 (enExample)
HR (1) HRP20050328A2 (enExample)
IS (1) IS7755A (enExample)
MX (1) MXPA05004058A (enExample)
PA (1) PA8586601A1 (enExample)
PE (1) PE20040777A1 (enExample)
PL (1) PL376218A1 (enExample)
TN (1) TNSN05111A1 (enExample)
UY (1) UY28024A1 (enExample)
WO (1) WO2004035575A1 (enExample)
ZA (1) ZA200502411B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1713504B1 (en) * 2004-01-30 2017-06-07 Zoetis Services LLC Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
ES2296131T3 (es) * 2004-02-02 2008-04-16 Pfizer Products Incorporated Procedimiento para la preparacion de 1-(2s,3s)-2-bencidril-n-(5-terc-butil-2-metoxibencil)quinuclidin-3-amina.
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh) 2008-12-23 2011-11-23 贝林格尔.英格海姆国际有限公司 有机化合物的盐形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
KR101819609B1 (ko) 2010-05-05 2018-01-17 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
MX366629B (es) 2011-07-15 2019-07-17 Boehringer Ingelheim Int Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
US10155000B2 (en) 2016-06-10 2018-12-18 Boehringer Ingelheim International Gmbh Medical use of pharmaceutical combination or composition
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法
CN108341811A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 马罗皮坦杂质的制备方法
CN106977512B (zh) * 2017-05-04 2019-01-01 海门慧聚药业有限公司 制备马罗匹坦游离碱的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560510A (en) * 1969-03-05 1971-02-02 Aldrich Chem Co Inc 2-benzhydrylquinuclidines
US4680283A (en) 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
US5138060A (en) 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
PL170513B1 (en) 1991-05-22 1996-12-31 Pfizer Method of obtaining novel derivatives of 3-amino quinuclidine
WO1992021677A1 (en) * 1991-05-31 1992-12-10 Pfizer Inc. bibNUCLIDINE DERIVATIVES
EP1114823A3 (en) 1992-08-19 2001-07-18 Pfizer Inc. Substituted benzylamino nitrogen containing non-aromatic heterocycles
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists
JP2656699B2 (ja) 1992-10-21 1997-09-24 ファイザー製薬株式会社 置換ベンジルアミノキヌクリジン
JP2656700B2 (ja) 1992-10-28 1997-09-24 ファイザー製薬株式会社 置換キヌクリジン誘導体
KR950704311A (ko) * 1992-11-12 1995-11-17 알렌 제이. 스피겔 물질 p 길항체로서의 퀴누클리딘 유도체(quinuclidine derivative as substance p antagonist)
IL109646A0 (en) 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
PE8798A1 (es) * 1995-07-17 1998-03-02 Pfizer Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
MX9706944A (es) 1996-09-12 1998-08-30 Pfizer Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p.

Also Published As

Publication number Publication date
CA2500635A1 (en) 2004-04-29
PE20040777A1 (es) 2004-11-20
AR041587A1 (es) 2005-05-26
US20050085641A1 (en) 2005-04-21
US20040116704A1 (en) 2004-06-17
IS7755A (is) 2005-03-17
CN1705664A (zh) 2005-12-07
UY28024A1 (es) 2004-05-31
HRP20050328A2 (en) 2005-06-30
MXPA05004058A (es) 2005-06-08
AU2003277353B2 (en) 2007-08-09
BR0315335A (pt) 2005-08-16
KR20050083764A (ko) 2005-08-26
WO2004035575A1 (en) 2004-04-29
TNSN05111A1 (en) 2007-05-14
KR100739901B1 (ko) 2007-07-13
HK1078087A1 (en) 2006-03-03
EA008192B1 (ru) 2007-04-27
AP2005003288A0 (en) 2005-06-30
US6861526B2 (en) 2005-03-01
JP2006506368A (ja) 2006-02-23
EP1551833A1 (en) 2005-07-13
EP1551833A4 (en) 2010-06-02
PL376218A1 (en) 2005-12-27
EA200500650A1 (ru) 2005-10-27
CN100418964C (zh) 2008-09-17
ZA200502411B (en) 2006-05-31
WO2004035575A8 (en) 2005-05-12
AU2003277353A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
PA8586601A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina
Liu et al. Trifluoromethylfluorosulfonylation of Unactivated Alkenes Using Readily Available Ag (O2CCF2SO2F) and N‐Fluorobenzenesulfonimide
CO6140053A2 (es) Proceso para fabricar 2-amino-5-halobenzamidas 3-sustituidas
CO5630034A1 (es) Metodo para producir esteres de alquilo
PE20091582A1 (es) Procedimiento para la preparacion de dihidropteridinonas
PE20021014A1 (es) Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad
CR6888A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
PT1222173E (pt) Processo para a preparacao de um derivado de 4-trifluorometil-sulfinilpirazole
Gao et al. Neighboring Lithium‐Assisted [1, 2]‐Wittig Rearrangement: Practical Access to Diarylmethanol‐Based 1, 4‐Diols and Optically Active BINOL Derivatives with Axial and sp3‐Central Chirality
AR063449A1 (es) Proceso quimico para derivados de quinazolina, intermediarios
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
Huang et al. A facile synthesis of β-amino carbonyl compounds through an aza-Michael addition reaction under solvent-free conditions
ES2130083A1 (es) Procedimiento para la obtencion de los enantiomeros de cizolirtina.
AR043505A1 (es) Preparacion de beta-cetoamidas e intermediarios de reaccion
BRPI0411195A (pt) método para a preparação de uma oxazinona fundida e método para a preparação de um composto
PA8594901A1 (es) Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina
TW200724495A (en) Nanowires and a method of the same
Kargbo et al. Synthesis of 3-benzazepines and azepino [4, 5-b] heterocyclic ring systems via intramolecular Friedel–Crafts cyclization
AR070754A1 (es) Proceso mejorado para preparar clorhidrato de cinacalcet
AR248391A1 (es) Procedimiento para la manufactura de 2-alcoximetil-acroleina, compuestos intermediarios prepararados a partir de la misma y procedimiento para preparar dichos intermediarios.
EA200201233A1 (ru) Способ получения бифенильных соединений
ES2568927T3 (es) Proceso para fabricar derivados de adamantano con alto rendimiento
AR047686A1 (es) Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable
DK1940772T3 (da) Ny fremgangsmåde til fremstilling af kvaternære syre- og ammoniumsalte
Quek et al. New highly efficient method for the synthesis of tert-alkyl nitroso compounds